Target intelligence / Profile preview

Oral pathogens

Molecular classification
Other
01

Overview

"Oral pathogens" is a collective, non-specific term referring to microbial species (primarily bacteria) in the oral microbiome that cause oral diseases, such as dental caries and periodontitis. Key bacterial genera/species include *Porphyromonas gingivalis*, *Streptococcus mutans*, *Tannerella forsythia*, *Fusobacterium nucleatum*, and *Prevotella intermedia*, among others[1][2][3][4]. These pathogens contribute to disease by forming biofilms, evading immune responses, producing toxins, and driving tissue inflammation and destruction. Therapies may target these organisms individually or as part of their complex communities, but "oral pathogens" itself is not a molecular target and cannot be mapped to a single canonical protein or receptor[2][4][6][9]. In summary, "oral pathogens" improperly refers to a diverse group of pathogenic microbes and not a single targetable molecular entity. This makes it unsuitable for structured molecular target mapping, and it should be replaced by a precise molecular target (such as "Porphyromonas gingivalis major fimbriae" or "Streptococcus mutans glucosyltransferase") when aiming for drug discovery or target-based research[2][4][6].

Other names
oral pathogenic bacteriaoral microbial pathogensoral infectious agentspathogenic oral microbiota
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis, targeting metabolic enzymes (e.g., pyruvate:ferredoxin oxidoreductase by amixicile), cell membrane disruption, bacteriophage-mediated lysis, bacteriocin-induced membrane perforation

03

Biological functions

InfectionBiofilm formationImmune modulationTissue destruction
04

Disease associations

InfectionPeriodontitisDental cariesOral mucositisEndodontic infectionsHalitosisSystemic disease links (e.g., cardiovascular disease when pathogens enter circulation)
05

Safety considerations

Broad-spectrum antibiotics disrupt commensal florarisk of antimicrobial resistancechallenges in selectively targeting only pathogenic speciespossible enhancement of dysbiosisvariable patient responses
06

Interacting drugs

Metronidazole

8 more in the full profile.

07

Biomarkers

Detection of key oral pathogens in plaque, saliva, or tissue by culture or 16S rRNA sequencingpresence of virulence factors (e.g., P. gingivalis major fimbriae, S. mutans glucosyltransferase)antibiotic resistance genesinflammatory mediators (e.g., cytokines)

Beyond the preview

Go deeper on Oral pathogens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral pathogens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call